BDBM350667 US10208071, Compound 129::US10434112, Compound 129::US10799518, Compound 129::propan-2-yl hydrogen {[(2- {[(4- bromophenyl)carbamoyl]amino} pentanoyl)amino]methyl} phosphonate

SMILES CC(C)C[C@H](NC(=O)Nc1ccc(Br)cc1)C(=O)NCP(O)(=O)OC(C)C

InChI Key InChIKey=PEHBGUYWYZGJBH-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350667   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350667(propan-2-yl hydrogen {[(2- {[(4- bromophenyl)carba...)
Affinity DataEC50:  1.87nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350667(propan-2-yl hydrogen {[(2- {[(4- bromophenyl)carba...)
Affinity DataEC50:  1.87nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350667(propan-2-yl hydrogen {[(2- {[(4- bromophenyl)carba...)
Affinity DataEC50:  1.87E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent